Medscape3 天
Emerging Resistance in Neisseria meningitidis and Neisseria gonorrhoeae
Expert Rev Anti Infect Ther. 2011;9(2):237-244.
pharmaphorum5 天
GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial
The pharma group, meanwhile, has another iron in the fire for gonorrhoea in the shape of its N. gonorrhoeae vaccine NgG, which is in phase 2 development and was awarded fast-track status from the ...